Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis

Vancouver, British Columbia, June 17, 2025 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”)  is pleased to report that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for patent application No. 18/1729,658 entitled, “Contact-Free Breath Analysis Device and Method” to the Company.

This patent application is centered on innovations made by Cannabix and its dual mode contactless (and traditional mouthpiece) breath capture and analysis technology. The technology has wide-ranging utility and can be integrated into everyday environments such as vehicles, workplaces, or public kiosks and supports fast, reliable testing without requiring physical contact. The technology can be used in unmanned breath devices, offering real-time feedback through visual indicators and displays and is well-suited for applications in law enforcement, workplace safety, and public health monitoring.  The system intelligently adjusts its internal airflow and pump mechanisms based on the sampling method, ensuring accurate and hygienic analysis.

This patent application further augments Cannabix’s leadership position at the forefront of breath sampling and detection techniques and continues to grow the intellectual capital of Cannabix’s breath capture and analytics portfolio. It should be noted that a notice of allowance from the USPTO does not constitute a grant of patent.  The Company will report on future material developments regarding its “Contact-Free Breath Analysis Device and Method” patent application in due course.